date,title,source
Nov-08-18,Stemline Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Stemline Therapeutics Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-16-18,Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at the 23rd Annual Meeting of the Society of Neuro-Oncology (SNO),GlobeNewswire
Nov-20-18,Stemline Therapeutics Announces that European Medicines Agency (EMA) Grants Accelerated Assessment for planned ELZONRIS Marketing Authorization Application (MAA),GlobeNewswire
Nov-21-18,What Kind Of Investor Owns Most Of Stemline Therapeutics Inc (NASDAQ:STML)?,Simply Wall St.
Nov-27-18,"Report: Developing Opportunities within Koppers, Flowers Foods, Stemline Therapeutics, Aqua Metals, athenahealth, and Bojangles'  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-30-18,"Stemline Therapeutics Highlights Four ELZONRIS Presentations, Including an Oral Presentation, at the Upcoming ASH Meeting",GlobeNewswire
Dec-06-18,Stemline Therapeutics Recaps Key Clinical Data Presentations from the American Society of Hematology (ASH) Annual Meeting,GlobeNewswire
Dec-07-18,"Stemline Therapeutics (STML): Elzonris Approval Dawning on the Horizon, Says Analyst",SmarterAnalyst
Dec-07-18,3 Biotech Stocks That Could Explode Higher in 2019,SmarterAnalyst
Dec-21-18,"FDA Approves ELZONRIS (tagraxofusp), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy",PR Newswire
Dec-21-18,U.S. FDA approves Stemline Therapeutics' rare blood disease treatment,Reuters
Dec-21-18,These 4 Biotech Stocks Are Raising Eyebrows,ACCESSWIRE
Dec-26-18,"Stemline's Elzonris Launch On Schedule, HC Wainwright Says In Bullish Initiation",Benzinga
Dec-26-18,"Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal",Zacks
Jan-02-19,Stemline Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-07-19,Stemline Therapeutics Announces Submission of European Marketing Authorization Application (MAA) for ELZONRIS,GlobeNewswire
Jan-14-19,Stemline Therapeutics Announces Proposed Public Offering of Common Stock,GlobeNewswire
Jan-15-19,Stemline Therapeutics Announces Upsizing and Pricing of $80 Million Public Offering of Common Stock,GlobeNewswire
Jan-16-19,Stemline Therapeutics (STML) in Focus: Stock Moves 9.5% Higher,Zacks
Jan-18-19,Stemline Therapeutics Closes $92 Million Public Offering of Common Stock,GlobeNewswire
Jan-24-19,"Consolidated Research: 2019 Summary Expectations for Marriott International, Calavo Growers, Kinsale Capital Group, Fluidigm, Goldman Sachs BDC, and Stemline Therapeutics  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Jan-30-19,Stemline Therapeutics Announces Validation of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA),GlobeNewswire
Feb-19-19,"Is Stemline Therapeutics, Inc. (NASDAQ:STML) Excessively Paying Its CEO?",Simply Wall St.
Mar-06-19,Stemline Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference,GlobeNewswire
Mar-11-19,Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline,GlobeNewswire
Mar-15-19,Stemline Therapeutics: 4Q Earnings Snapshot,Associated Press
Mar-15-19,Stemline Therapeutics Reports Fourth Quarter 2018 Financial Results,GlobeNewswire
Mar-18-19,Stemline Therapeutics to Participate in Panel on Myeloid Tumors at the 31st Annual ROTH Conference,GlobeNewswire
Apr-01-19,"Research Report Identifies Oracle, Realty Income, Stemline Therapeutics, WhiteHorse Finance, EverQuote, and Sanderson Farms with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Apr-23-19,Announcing: Stemline Therapeutics (NASDAQ:STML) Stock Increased An Energizing 150% In The Last Three Years,Simply Wall St.
Apr-25-19,Stemline Therapeutics Announces New England Journal of Medicine Publication of ELZONRIS (tagraxofusp) Pivotal Study Results,GlobeNewswire
